Literature DB >> 6425283

Nucleoside hydrolases from Trypanosoma cruzi.

R L Miller, C L Sabourin, T A Krenitsky, R L Berens, J J Marr.   

Abstract

Four distinct nucleoside cleaving enzymes were detected in extracts of Trypanosoma cruzi epimastigotes. Two of these were nucleoside phosphorylases: one was specific for pyrimidines and the other for purines. The other two enzymes were nucleoside hydrolases. These hydrolytic enzymes were partially purified and their substrate and inhibitor specificities were studied. One of the hydrolases was designated inosine/guanosine hydrolase. It required purine substrates containing a 9-beta-D-ribofuranosyl substituent. Neither 2'-deoxyinosine, 2'-deoxyguanosine, nor hypoxanthine arabinoside served as substrates. The kinetic patterns obtained from combined product analysis and the mutual competitive inhibition of this enzyme by inosine and guanosine suggested that these substrates were cleaved at a common catalytic site. Inhibitor studies with several deoxyinosines have demonstrated the importance of the 2'-, 3'-, and 5'-hydroxyl groups for efficient binding to the enzyme. Adenosine, which did not serve as a substrate, was a potent competitive inhibitor (Ki = 8 microM) with respect to both inosine and guanosine. This enzyme had a particle weight of 106,000 +/- 10,000 as determined by Sephadex chromatography. The other hydrolase was specific for 2'-deoxyinosine. It only accepted purine substrates with a 6-oxo- and a 9-beta-D-2'-deoxyribofuranosyl substituent. Inosine, hypoxanthine arabinoside and a variety of deoxyinosines were not substrates nor did they strongly inhibit this enzyme. This enzyme had a particle weight of 19,000 +/- 2,000 as determined by Sephadex chromatography.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6425283

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Structural and biochemical characterization of the nucleoside hydrolase from C. elegans reveals the role of two active site cysteine residues in catalysis.

Authors:  Ranjan Kumar Singh; Jan Steyaert; Wim Versées
Journal:  Protein Sci       Date:  2017-03-06       Impact factor: 6.725

2.  Solution structure of the nucleotide hydrolase BlsM: Implication of its substrate specificity.

Authors:  Minhee Kang; Kiran Doddapaneni; Samantha Sarni; Zach Heppner; Vicki Wysocki; Zhengrong Wu
Journal:  Protein Sci       Date:  2020-08       Impact factor: 6.725

3.  Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis.

Authors:  Ingrid Aguilar-Be; Renata da Silva Zardo; Edilma Paraguai de Souza; Gulnara Patrícia Borja-Cabrera; Miguel Rosado-Vallado; Mirza Mut-Martin; Maria del Rosario García-Miss; Clarisa Beatriz Palatnik de Sousa; Eric Dumonteil
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

4.  Transition-state analysis of Trypanosoma cruzi uridine phosphorylase-catalyzed arsenolysis of uridine.

Authors:  Rafael G Silva; Mathew J Vetticatt; Emilio F Merino; Maria B Cassera; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2011-06-03       Impact factor: 15.419

5.  Biological activity of analogs of guanine and guanosine against American Trypanosoma and Leishmania spp.

Authors:  J L Avila; T Rojas; A Avila; M A Polegre; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

6.  Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective response.

Authors:  Dirlei Nico; Carla Claser; Gulnara P Borja-Cabrera; Luiz R Travassos; Marcos Palatnik; Irene da Silva Soares; Mauricio Martins Rodrigues; Clarisa B Palatnik-de-Sousa
Journal:  PLoS Negl Trop Dis       Date:  2010-11-09

7.  Substrate specificity of the purine-2'-deoxyribonucleosidase of Crithidia luciliae.

Authors:  D J Steenkamp; T J Hälbich
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

8.  Pyrazolopyrimidine metabolism in parasitic protozoa.

Authors:  B Ullman
Journal:  Pharm Res       Date:  1984-09       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.